Shoulder Innovations (NYSE:SI) CFO Jeffrey Points Acquires 2,000 Shares of Stock

Shoulder Innovations, Inc. (NYSE:SI) CFO Jeffrey Points bought 2,000 shares of the company’s stock in a transaction that occurred on Friday, March 13th. The shares were acquired at an average cost of $15.00 per share, with a total value of $30,000.00. Following the transaction, the chief financial officer owned 70,785 shares in the company, valued at approximately $1,061,775. This represents a 2.91% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Shoulder Innovations Price Performance

SI opened at $15.20 on Wednesday. Shoulder Innovations, Inc. has a 52-week low of $10.92 and a 52-week high of $17.94. The company has a 50 day moving average of $13.76 and a two-hundred day moving average of $13.85. The company has a market cap of $313.88 million and a P/E ratio of -0.07. The company has a quick ratio of 9.55, a current ratio of 11.07 and a debt-to-equity ratio of 0.11.

Shoulder Innovations (NYSE:SI) last posted its earnings results on Tuesday, March 10th. The company reported ($0.38) earnings per share for the quarter, beating the consensus estimate of ($0.42) by $0.04. Shoulder Innovations had a negative net margin of 85.29% and a negative return on equity of 37.68%. The business had revenue of $14.42 million for the quarter, compared to analyst estimates of $12.69 million. On average, analysts expect that Shoulder Innovations, Inc. will post -0.56 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on SI shares. Weiss Ratings reiterated a “sell (e)” rating on shares of Shoulder Innovations in a report on Monday, December 29th. Morgan Stanley upped their price target on Shoulder Innovations from $18.00 to $23.00 and gave the stock an “overweight” rating in a report on Tuesday, December 2nd. The Goldman Sachs Group reaffirmed a “buy” rating on shares of Shoulder Innovations in a research report on Friday, January 9th. Finally, BTIG Research boosted their target price on shares of Shoulder Innovations from $23.00 to $24.00 and gave the stock a “buy” rating in a research report on Wednesday, March 11th. Five equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $20.80.

Institutional Investors Weigh In On Shoulder Innovations

A number of hedge funds have recently bought and sold shares of SI. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in Shoulder Innovations during the 3rd quarter worth approximately $28,000. Rhumbline Advisers purchased a new position in shares of Shoulder Innovations during the 3rd quarter valued at approximately $54,000. Wells Fargo & Company MN grew its position in shares of Shoulder Innovations by 66.3% during the fourth quarter. Wells Fargo & Company MN now owns 5,250 shares of the company’s stock worth $75,000 after buying an additional 2,094 shares in the last quarter. Board of Trustees of The Leland Stanford Junior University bought a new stake in shares of Shoulder Innovations in the third quarter worth $170,000. Finally, Renaissance Technologies LLC bought a new stake in shares of Shoulder Innovations in the fourth quarter worth $176,000.

About Shoulder Innovations

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.